IPP Bureau
Claim against Dr. Reddy’s Laboratories dismissed over Revlimid in US
By IPP Bureau - December 30, 2022
All claims against the company in the litigation have now been dismissed.
Samples taken from Marion Biotech Noida facility sent to RDTL, Chandigarh for testing
By IPP Bureau - December 30, 2022
There have been reports from Uzbekistan concerning contaminated cough syrup Dok1 Max made by Indian company Marion Biotech, Noida, Uttar Pradesh
Eye-Q inaugurates its new facility in Yamunanagar
By IPP Bureau - December 30, 2022
The new facility will be able to handle four times as many patients as the previous facility.
Mandaviya and Puri hail MoU between IndianOil and Central TB Division for states of UP and Chhattisgarh
By IPP Bureau - December 29, 2022
This ambitious anti-TB campaign, as part of IOCL’s CSR, aims to ensure early identification of presumptive TB and prompt diagnosis using high-sensitivity diagnostic tests at the doorstep
Stelis Biopharma’s CDMO partner receives approval for key ANDA from the USFDA
By IPP Bureau - December 29, 2022
The current approval is first of the many fillings made by the company's CDMO partners from the flagship facility in Bangalore
Hester to develop low pathogenic avian influenza inactivated vaccine for poultry
By IPP Bureau - December 29, 2022
The company has plans to launch this Vaccine by the end of 2023 after completing the required field studies and obtaining regulatory approvals
World's first intranasal vaccine iNCOVACC will be rolled out in the fourth week of January
By IPP Bureau - December 29, 2022
The vectored intranasal delivery platform gives us the capability for rapid product development, scale-up, easy and painless immunization during public health emergencies and pandemics
AIIMS organises consultation on ‘C2IQ’
By IPP Bureau - December 29, 2022
For anaemia control in children (0-19 years) & resolves for Call to Action in this direction
CDSCO and State Drugs Control Administration commence joint inspection of drug manufacturing units
By IPP Bureau - December 28, 2022
A committee of two Joint Drugs Controllers has been constituted at CDSCO to monitor the process of inspection, reporting, and subsequent action to ensure compliance to the Drugs & Cosmetics Act, 1940
Mandaviya visits Safdarjung Hospital; Reviews mock drill for ensuring readiness for COVID-19 management
By IPP Bureau - December 28, 2022
Mock drills are being conducted across the country to review the preparedness for management of COVID-19
Aurobindo's subsidiary Tergene Biotech receives SEC recommendation for pneumococcal 15 valent vaccine
By IPP Bureau - December 28, 2022
The company continue to develop this program for the WHO markets, thereby providing coverage and protection for more infants globally in time to come
Amcor sells factories in Russia
By IPP Bureau - December 28, 2022
The cash and debt free consideration value is €370 million.
Ablaze and Yonghe Pharma initiate development and manufacturing agreement for targeted radiopharmaceutical therapies
By IPP Bureau - December 28, 2022
Yonghe as the CDMO partner will provide production process development and cGMP manufacturing services for Ablaze
